Cargando…
Corneal perforation in ocular graft-versus-host disease
PURPOSE: Corneal perforation is a rare, vision-threatening complication of ocular graft-versus-host disease (GVHD) and is not well understood. Our objective was to examine the clinical disease course and histopathologic correlation in patients who progressed to this outcome. METHODS: This study is a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586569/ https://www.ncbi.nlm.nih.gov/pubmed/34805617 http://dx.doi.org/10.1016/j.ajoc.2021.101224 |
_version_ | 1784597914405830656 |
---|---|
author | Zhang, Cathy Y. Farooq, Asim V. Harocopos, George J. Sollenberger, Eric L. Hou, Joshua H. Bouchard, Charles S. Shieh, Christine Tran, Uyen L. Lubniewski, Anthony J. Huang, Andrew J.W. Paley, Grace L. |
author_facet | Zhang, Cathy Y. Farooq, Asim V. Harocopos, George J. Sollenberger, Eric L. Hou, Joshua H. Bouchard, Charles S. Shieh, Christine Tran, Uyen L. Lubniewski, Anthony J. Huang, Andrew J.W. Paley, Grace L. |
author_sort | Zhang, Cathy Y. |
collection | PubMed |
description | PURPOSE: Corneal perforation is a rare, vision-threatening complication of ocular graft-versus-host disease (GVHD) and is not well understood. Our objective was to examine the clinical disease course and histopathologic correlation in patients who progressed to this outcome. METHODS: This study is a retrospective case series from four academic centers in the United States. All patients received a hematopoietic stem cell transplant (HSCT) prior to developing ocular GVHD. Variables of interest included patient demographics, time interval between HSCT and ocular events, visual acuity throughout clinical course, corticosteroid and infection prophylaxis regimens at time of corneal perforation, medical/surgical interventions, and histopathology. RESULTS: Fourteen eyes from 14 patients were analyzed. Most patients were male (86%) and Caucasian (86%), and average age at time of hematopoietic stem cell transplant was 47 years. The mean interval between hematopoietic stem cell transplant and diagnosis of ocular graft-versus-host disease was 9.5 months, and between hematopoietic stem cell transplant and corneal perforation was 37 months. Initial best-corrected visual acuity was 20/40 or better in 9 eyes, and all eyes had moderate or poor visual outcomes despite aggressive management, including corneal gluing in all patients followed by keratoplasty in 8 patients. The mean follow-up after perforation was 34 months (range 2–140 months). Oral prednisone was used prior to perforation in 11 patients (79%). On histopathology, representative specimens in the acute phase demonstrated ulcerative keratitis with perforation but minimal inflammatory cells and no microorganisms, consistent with sterile corneal “melt” in the setting of immunosuppression; and in the healed phase, filling in of the perforation site with fibrous scar. CONCLUSIONS: In these patients, an extended time interval was identified between the diagnosis of ocular graft-versus-host disease and corneal perforation. This represents a critical window to potentially prevent this devastating outcome. Further study is required to identify those patients at greatest risk as well as to optimize prevention strategies. |
format | Online Article Text |
id | pubmed-8586569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-85865692021-11-19 Corneal perforation in ocular graft-versus-host disease Zhang, Cathy Y. Farooq, Asim V. Harocopos, George J. Sollenberger, Eric L. Hou, Joshua H. Bouchard, Charles S. Shieh, Christine Tran, Uyen L. Lubniewski, Anthony J. Huang, Andrew J.W. Paley, Grace L. Am J Ophthalmol Case Rep Brief Report PURPOSE: Corneal perforation is a rare, vision-threatening complication of ocular graft-versus-host disease (GVHD) and is not well understood. Our objective was to examine the clinical disease course and histopathologic correlation in patients who progressed to this outcome. METHODS: This study is a retrospective case series from four academic centers in the United States. All patients received a hematopoietic stem cell transplant (HSCT) prior to developing ocular GVHD. Variables of interest included patient demographics, time interval between HSCT and ocular events, visual acuity throughout clinical course, corticosteroid and infection prophylaxis regimens at time of corneal perforation, medical/surgical interventions, and histopathology. RESULTS: Fourteen eyes from 14 patients were analyzed. Most patients were male (86%) and Caucasian (86%), and average age at time of hematopoietic stem cell transplant was 47 years. The mean interval between hematopoietic stem cell transplant and diagnosis of ocular graft-versus-host disease was 9.5 months, and between hematopoietic stem cell transplant and corneal perforation was 37 months. Initial best-corrected visual acuity was 20/40 or better in 9 eyes, and all eyes had moderate or poor visual outcomes despite aggressive management, including corneal gluing in all patients followed by keratoplasty in 8 patients. The mean follow-up after perforation was 34 months (range 2–140 months). Oral prednisone was used prior to perforation in 11 patients (79%). On histopathology, representative specimens in the acute phase demonstrated ulcerative keratitis with perforation but minimal inflammatory cells and no microorganisms, consistent with sterile corneal “melt” in the setting of immunosuppression; and in the healed phase, filling in of the perforation site with fibrous scar. CONCLUSIONS: In these patients, an extended time interval was identified between the diagnosis of ocular graft-versus-host disease and corneal perforation. This represents a critical window to potentially prevent this devastating outcome. Further study is required to identify those patients at greatest risk as well as to optimize prevention strategies. Elsevier 2021-10-28 /pmc/articles/PMC8586569/ /pubmed/34805617 http://dx.doi.org/10.1016/j.ajoc.2021.101224 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Brief Report Zhang, Cathy Y. Farooq, Asim V. Harocopos, George J. Sollenberger, Eric L. Hou, Joshua H. Bouchard, Charles S. Shieh, Christine Tran, Uyen L. Lubniewski, Anthony J. Huang, Andrew J.W. Paley, Grace L. Corneal perforation in ocular graft-versus-host disease |
title | Corneal perforation in ocular graft-versus-host disease |
title_full | Corneal perforation in ocular graft-versus-host disease |
title_fullStr | Corneal perforation in ocular graft-versus-host disease |
title_full_unstemmed | Corneal perforation in ocular graft-versus-host disease |
title_short | Corneal perforation in ocular graft-versus-host disease |
title_sort | corneal perforation in ocular graft-versus-host disease |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586569/ https://www.ncbi.nlm.nih.gov/pubmed/34805617 http://dx.doi.org/10.1016/j.ajoc.2021.101224 |
work_keys_str_mv | AT zhangcathyy cornealperforationinoculargraftversushostdisease AT farooqasimv cornealperforationinoculargraftversushostdisease AT harocoposgeorgej cornealperforationinoculargraftversushostdisease AT sollenbergerericl cornealperforationinoculargraftversushostdisease AT houjoshuah cornealperforationinoculargraftversushostdisease AT bouchardcharless cornealperforationinoculargraftversushostdisease AT shiehchristine cornealperforationinoculargraftversushostdisease AT tranuyenl cornealperforationinoculargraftversushostdisease AT lubniewskianthonyj cornealperforationinoculargraftversushostdisease AT huangandrewjw cornealperforationinoculargraftversushostdisease AT paleygracel cornealperforationinoculargraftversushostdisease |